Literature DB >> 9585570

The role of Gly-4 of human cystatin A (stefin A) in the binding of target proteinases. Characterization by kinetic and equilibrium methods of the interactions of cystatin A Gly-4 mutants with papain, cathepsin B, and cathepsin L.

S Estrada1, M Nycander, N J Hill, C J Craven, J P Waltho, I Björk.   

Abstract

The importance of the evolutionarily conserved Gly-4 residue for the affinity and kinetics of interaction of cystatin A with several cysteine proteinases was assessed by site-directed mutagenesis. Even the smallest replacement, by Ala, resulted in approximately 1000-, approximately 10- and approximately 6000-fold decreased affinities for papain, cathepsin L, and cathepsin B, respectively. Substitution by Ser gave further 3-8-fold reductions in affinity, whereas the largest decreases, >10(5)-fold, were observed for mutations to Arg and Glu. The kinetics of inhibition of papain by the mutants with small side chains, Ala and Ser, were compatible with a one-step bimolecular reaction similar to that with wild-type cystatin A. The decreased affinities of these mutants for papain and cathepsin L were due exclusively to increased dissociation rate constants, but the reduced affinities for cathepsin B were due also to decreased association rate constants. The latter finding indicates that the intact N-terminal region serves as a guide directing cystatin A to the active site of cathepsin B, as has been proposed for cystatin C. The kinetics of binding of the mutants with charged side chains, Arg and Glu, to papain were consistent with a two-step binding mechanism, in which the mutant side chains are accommodated in the complex by a conformational change. The NMR solution structure of the Ala and Trp mutants showed only minor changes compared with wild-type cystatin A, indicating that the large reductions in affinity for proteinases are not due to altered structures of the mutants. Instead, a side chain larger than a hydrogen atom at position 4 affects the interaction with the proteinase most likely by interfering with the binding of the N-terminal region.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585570     DOI: 10.1021/bi980026r

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Functional expression of recombinant human stefin A in mammalian and bacterial cells.

Authors:  Catharine C Calkins; Julie Dosescu; Nancy A Day; Wei-Ping Ren; Rafael Fridman; Bonnie F Sloane; Kamiar Moin
Journal:  Protein Expr Purif       Date:  2006-12-09       Impact factor: 1.650

2.  The N-terminal region of cystatin A (stefin A) binds to papain subsequent to the two hairpin loops of the inhibitor. Demonstration of two-step binding by rapid-kinetic studies of cystatin A labeled at the N-terminus with a fluorescent reporter group.

Authors:  S Estrada; S T Olson; E Raub-Segall; I Björk
Journal:  Protein Sci       Date:  2000-11       Impact factor: 6.725

Review 3.  Cathepsin B as a cancer target.

Authors:  Christopher S Gondi; Jasti S Rao
Journal:  Expert Opin Ther Targets       Date:  2013-01-08       Impact factor: 6.902

4.  Role of the single cysteine residue, Cys 3, of human and bovine cystatin B (stefin B) in the inhibition of cysteine proteinases.

Authors:  E Pol; I Björk
Journal:  Protein Sci       Date:  2001-09       Impact factor: 6.725

Review 5.  The macrophage marches on its phagosome: dynamic assays of phagosome function.

Authors:  David G Russell; Brian C Vanderven; Sarah Glennie; Henry Mwandumba; Robert S Heyderman
Journal:  Nat Rev Immunol       Date:  2009-07-10       Impact factor: 53.106

6.  Structure-function studies of an engineered scaffold protein derived from stefin A. I: Development of the SQM variant.

Authors:  Toni Hoffmann; Lukas Kurt Josef Stadler; Michael Busby; Qifeng Song; Anthony T Buxton; Simon D Wagner; Jason J Davis; Paul Ko Ferrigno
Journal:  Protein Eng Des Sel       Date:  2010-02-23       Impact factor: 1.650

7.  Cystatin a, a potential common link for mutant myocilin causative glaucoma.

Authors:  K David Kennedy; S A AnithaChristy; Lakisha K Buie; Teresa Borrás
Journal:  PLoS One       Date:  2012-05-15       Impact factor: 3.240

8.  Cell cycle- and cancer-associated gene networks activated by Dsg2: evidence of cystatin A deregulation and a potential role in cell-cell adhesion.

Authors:  Abhilasha Gupta; Daniela Nitoiu; Donna Brennan-Crispi; Sankar Addya; Natalia A Riobo; David P Kelsell; Mỹ G Mahoney
Journal:  PLoS One       Date:  2015-03-18       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.